Related references
Note: Only part of the references are listed.The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
Kevin J. Whitehead et al.
NATURE MEDICINE (2009)
Proteomic identification of the cerebral cavernous malformation signaling complex
Thomas L. Hilder et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Screening for PTB domain binding partners and ligand specificity using proteome-derived NPXY peptide arrays
Matthew J. Smith et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis
JS Zawistowski et al.
HUMAN MOLECULAR GENETICS (2005)
Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation
M Yamashita et al.
CELL (2005)
The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture
RJ Ingham et al.
ONCOGENE (2004)
Regulation of cell polarity and protrusion formation by targeting RhoA for degradation
HR Wang et al.
SCIENCE (2003)
Vascular morphogenesis: tales of two syndromes
DA Marchuk et al.
HUMAN MOLECULAR GENETICS (2003)
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock
MT Uhlik et al.
NATURE CELL BIOLOGY (2003)
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations
CL Liquori et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Rho GTPases and the regulation of endothelial permeability
B Wojciak-Stothard et al.
VASCULAR PHARMACOLOGY (2002)
Share Paper
